TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T08522 XX ID T08522 XX DT 02.02.2006 (created); jag. CO Copyright (C), QIAGEN. XX FA HDAC4-isoform1 XX SY AHO3; BDMR; HA6116; HD4; HDAC-4; HDAC-A; HDAC4; HDACA; histone deacetylase 4; KIAA0288. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G007850 HDAC4; HGNC: HDAC4. XX SZ 1084 AA; 119.0 kDa (cDNA) (calc.). XX SQ MSSQSHPDGLSGRDQPVELLNPARVNHMPSTVDVATALPLQVAPSAVPMDLRLDHQFSLP SQ VAEPALREQQLQQELLALKQKQQIQRQILIAEFQRQHEQLSRQHEAQLHEHIKQQQEMLA SQ MKHQQELLEHQRKLERHRQEQELEKQHREQKLQQLKNKEKGKESAVASTEVKMKLQEFVL SQ NKKKALAHRNLNHCISSDPRYWYGKTQHSSLDQSSPPQSGVSTSYNHPVLGMYDAKDDFP SQ LRKTASEPNLKLRSRLKQKVAERRSSPLLRRKDGPVVTALKKRPLDVTDSACSSAPGSGP SQ SSPNNSSGSVSAENGIAPAVPSIPAETSLAHRLVAREGSAAPLPLYTSPSLPNITLGLPA SQ TGPSAGTAGQQDAERLTLPALQQRLSLFPGTHLTPYLSTSPLERDGGAAHSPLLQHMVLL SQ EQPPAQAPLVTGLGALPLHAQSLVGADRVSPSIHKLRQHRPLGRTQSAPLPQNAQALQHL SQ VIQQQHQQFLEKHKQQFQQQQLQMNKIIPKPSEPARQPESHPEETEEELREHQALLDEPY SQ LDRLPGQKEAHAQAGVQVKQEPIESDEEEAEPPREVEPGQRQPSEQELLFRQQALLLEQQ SQ RIHQLRNYQASMEAAGIPVSFGGHRPLSRAQSSPASATFPVSVQEPPTKPRFTTGLVYDT SQ LMLKHQCTCGSSSSHPEHAGRIQSIWSRLQETGLRGKCECIRGRKATLEELQTVHSEAHT SQ LLYGTNPLNRQKLDSKKLLGSLASVFVRLPCGGVGVDSDTIWNEVHSAGAARLAVGCVVE SQ LVFKVATGELKNGFAVVRPPGHHAEESTPMGFCYFNSVAVAAKLLQQRLSVSKILIVDWD SQ VHHGNGTQQAFYSDPSVLYMSLHRYDDGNFFPGSGAPDEVGTGPGVGFNVNMAFTGGLDP SQ PMGDAEYLAAFRTVVMPIASEFAPDVVLVSSGFDAVEGHPTPLGGYNLSARCFGYLTKQL SQ MGLAGGRIVLALEGGHDLTAICDASEACVSALLGNELDPLPEKVLQQRPNANAVRSMEKV SQ MEIHSKYWRCLQRTTSTAGRSLIEAQTCENEEAETVTAMASLSVGVKPAEKRPDEEPMEE SQ EPPL XX SC Swiss-Prot#P56524 XX FT 1 208 Targeting MEF2 to punctuate nuclear bodies [16]. FT 28 568 PF00478; IMP dehydrogenase / GMP reductase domai. FT 43 57 CtBP binding domain [16]. FT 119 208 HDAC1 binding domain [16]. FT 408 510 HP1 binding domain [16]. FT 653 998 PF00850; Histone deacetylase domain. FT 803 846 N-CoR/SMRT/HDAC3 binding domain [16]. XX IN T03984 AML3-isoform1; human, Homo sapiens. IN T34300 BCOR-isoform2; human, Homo sapiens. IN T34301 BCOR-S; human, Homo sapiens. IN T08291 GATA-1-isoform1; mouse, Mus musculus. IN T08343 HDAC1; human, Homo sapiens. IN T04110 HDAC3; human, Homo sapiens. IN T09402 MEF-2C; Mammalia. IN T09547 MEF-2C; mouse, Mus musculus. IN T33892 MTA-1; Mammalia. IN T08641 NCOR1-isoform1; mouse, Mus musculus. IN T04687 NCOR1; human, Homo sapiens. IN T05441 RFXANK; human, Homo sapiens. IN T29717 SIRT1; human, Homo sapiens. IN T04689 SMRT; human, Homo sapiens. IN T00759 Sp1; human, Homo sapiens. XX DR TRANSPATH: MO000059566. DR EMBL: AF132607; DR UniProtKB: P56524; XX RN [1]; RE0025804. RX PUBMED: 14668799. RA Watamoto K., Towatari M., Ozawa Y., Miyata Y., Okamoto M., Abe A., Naoe T., Saito H. RT Altered interaction of HDAC5 with GATA-1 during MEL cell differentiation. RL Oncogene 22:9176-84 (2003). RN [2]; RE0026599. RX PUBMED: 10898795. RA Huynh K. D., Fischle W., Verdin E., Bardwell V. J. RT BCoR, a novel corepressor involved in BCL-6 repression. RL Genes Dev. 14:1810-23 (2000). RN [3]; RE0027552. RX PUBMED: 10640275. RA Huang E. Y., Zhang J., Miska E. A., Guenther M. G., Kouzarides T., Lazar M. A. RT Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway. RL Genes Dev. 14:45-54 (2000). RN [4]; RE0029293. RX PUBMED: 11804585. RA Fischle W., Dequiedt F., Hendzel M. J., Guenther M. G., Lazar M. A., Voelter W., Verdin E. RT Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. RL Mol. Cell 9:45-57 (2002). RN [5]; RE0047615. RX PUBMED: 16051668. RA Leong H., Sloan J. R., Nash P. D., Greene G. L. RT Recruitment of histone deacetylase 4 to the N-terminal region of estrogen receptor alpha. RL Mol. Endocrinol. 19:2930-2942 (2005). RN [6]; RE0048077. RX PUBMED: 15537544. RA Vega R. B., Matsuda K., Oh J., Barbosa A. C., Yang X., Meadows E., McAnally J., Pomajzl C., Shelton J. M., Richardson J. A., Karsenty G., Olson E. N. RT Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. RL Cell 119:555-566 (2004). RN [7]; RE0048095. RX PUBMED: 15743821. RA Micheli L., Leonardi L., Conti F., Buanne P., Canu N., Caruso M., Tirone F. RT PC4 coactivates MyoD by relieving the histone deacetylase 4-mediated inhibition of myocyte enhancer factor 2C. RL Mol. Cell. Biol. 25:2242-2259 (2005). RN [8]; RE0048124. RX PUBMED: 16356933. RA Gregoire S., Tremblay A. M., Xiao L., Yang Q., Ma K., Nie J., Mao Z., Wu Z., Giguere V., Yang X. J. RT Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. RL J. Biol. Chem. 281:4423-4433 (2006). RN [9]; RE0048453. RX PUBMED: 12032081. RA Kirsh O., Seeler J. S., Pichler A., Gast A., Muller S., Miska E., Mathieu M., Harel-Bellan A., Kouzarides T., Melchior F., Dejean A. RT The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. RL EMBO J. 21:2682-2691 (2002). RN [10]; RE0048484. RX PUBMED: 10860984. RA Wen Y. D., Perissi V., Staszewski L. M., Yang W. M., Krones A., Glass C. K., Rosenfeld M. G., Seto E. RT The histone deacetylase-3 complex contains nuclear receptor corepressors. RL Proc. Natl. Acad. Sci. USA 97:7202-7207 (2000). RN [11]; RE0052069. RX PUBMED: 12242305. RA Zhang C. L., McKinsey T. A., Olson E. N. RT Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation. RL Mol. Cell. Biol. 22:7302-7312 (2002). RN [12]; RE0052481. RX PUBMED: 12590135. RA Petrie K., Guidez F., Howell L., Healy L., Waxman S., Greaves M., Zelent A. RT The histone deacetylase 9 gene encodes multiple protein isoforms. RL J. Biol. Chem. 278:16059-16072 (2003). RN [13]; RE0054734. RX PUBMED: 18632985. RA Wilson A. J., Byun D. S., Nasser S., Murray L. B., Ayyanar K., Arango D., Figueroa M., Melnick A., Kao G. D., Augenlicht L. H., Mariadason J. M. RT HDAC4 promotes growth of colon cancer cells via repression of p21. RL Mol. Biol. Cell 19:4062-4075 (2008). RN [14]; RE0070855. RX PUBMED: 18691969. RA Knipscheer P., Flotho A., Klug H., Olsen J. V., van Dijk W. J., Fish A., Johnson E. S., Mann M., Sixma T. K., Pichler A. RT Ubc9 sumoylation regulates SUMO target discrimination. RL Mol. Cell 31:371-382 (2008). RN [15]; RE0071301. RX PUBMED: 17491593. RA Knipscheer P., van Dijk W. J., Olsen J. V., Mann M., Sixma T. K. RT Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation. RL EMBO J. 26:2797-2807 (2007). RN [16]; RE0048576. RX PUBMED: 12709441. RA Chan J. K., Sun L., Yang X. J., Zhu G., Wu Z. RT Functional characterization of an amino-terminal region of HDAC4 that possesses MEF2 binding and transcriptional repressive activity. RL J. Biol. Chem. 278:23515-23521 (2003). XX //